Ca2+/calmodulin-dependent kinase IIdelta causes heart failure by accumulation of p53 in dilated cardiomyopathy

Haruhiro Toko1, Hidehisa Takahashi, Yosuke Kayama

  • 1Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Circulation
|August 18, 2010
PubMed
Abstract

Insights

A mutated cardiac alpha-actin gene caused dilated cardiomyopathy (DCM) in mice, leading to heart failure. Calcium/calmodulin-dependent kinase IIdelta (CaMKIIdelta) activation contributes to DCM by increasing p53 and cardiomyocyte apoptosis.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Genetics of Heart Disease

Background:

  • Dilated cardiomyopathy (DCM) is a major cause of heart failure, characterized by left ventricular dilation and dysfunction.
  • Genetic mutations, particularly in cytoskeletal and contractile protein genes, are implicated in DCM, but underlying mechanisms remain unclear.

Purpose of the Study:

  • To establish and characterize a mouse model of DCM using a mutated cardiac alpha-actin gene.
  • To investigate the molecular mechanisms linking genetic mutations to DCM pathogenesis and heart failure.

Main Methods:

  • Generation of transgenic mice (mActin-Tg) expressing a DCM-associated mutated cardiac alpha-actin gene.
  • Assessment of cardiac function, cardiomyocyte apoptosis, p53 protein levels, myofilament calcium sensitivity, and CaMKIIdelta activity in mActin-Tg mice.
  • Pharmacological inhibition of CaMKIIdelta to evaluate its role in DCM progression.

Main Results:

  • mActin-Tg mice exhibited progressive left ventricular dilatation, dysfunction, and heart failure, mimicking human DCM.
  • Increased cardiomyocyte apoptosis and elevated p53 levels were observed in mActin-Tg hearts.
  • Reduced myofilament calcium sensitivity and activated CaMKIIdelta were detected.
  • Inhibition of CaMKIIdelta attenuated cardiomyocyte apoptosis, improved cardiac function, and reduced p53 accumulation.

Conclusions:

  • CaMKIIdelta plays a crucial role in DCM pathogenesis and heart failure development.
  • CaMKIIdelta contributes to DCM by promoting p53 accumulation and cardiomyocyte apoptosis.
  • This mActin-Tg mouse model provides a valuable tool for studying DCM mechanisms and testing therapeutic strategies.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...